Figg, W D <br/><br/>
A phase I study of the somatostatin analogue somatuline in patients with metastatic hormone-refractory prostate cancer.  [electronic resource] 

 -  Cancer  Apr 1995 
 - 2159-64 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Clinical Trial, Phase I; Journal Article; Research Support, U.S. Gov't, Non-P.H.S. 
<br/><br/><label>ISSN: </label>0008-543X 
<br/><br/><label>Standard No.: </label>10.1002/1097-0142(19950415)75:8<2159::aid-cncr2820750820>3.0.co;2-o  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Aged, 80 and over<br/>Amino Acid Sequence<br/>Antineoplastic Agents--administration & dosage<br/>Drug Administration Schedule<br/>Humans<br/>Insulin-Like Growth Factor I--analysis<br/>Insulin-Like Growth Factor II--analysis<br/>Male<br/>Middle Aged<br/>Molecular Sequence Data<br/>Neoplasms, Hormone-Dependent--blood<br/>Octreotide--administration & dosage<br/>Peptides, Cyclic<br/>Prostate-Specific Antigen--blood<br/>Prostatic Neoplasms--blood<br/>Somatostatin--analogs & derivatives